HomeNMRA • NASDAQ
add
Neumora Therapeutics Inc
Previous close
$0.81
Day range
$0.81 - $0.92
Year range
$0.61 - $17.19
Market cap
146.78M USD
Avg Volume
811.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 70.94M | 18.08% |
Net income | -67.99M | -26.57% |
Net profit margin | — | — |
Earnings per share | -0.42 | -23.53% |
EBITDA | -70.78M | -18.13% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 249.35M | -41.01% |
Total assets | 256.75M | -42.97% |
Total liabilities | 28.38M | 10.58% |
Total equity | 228.36M | — |
Shares outstanding | 161.75M | — |
Price to book | 0.57 | — |
Return on assets | -61.82% | — |
Return on capital | -68.44% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -67.99M | -26.57% |
Cash from operations | -59.45M | -38.40% |
Cash from investing | 44.16M | 129.44% |
Cash from financing | — | — |
Net change in cash | -15.29M | 92.00% |
Free cash flow | -34.48M | -26.86% |
About
Founded
2019
Headquarters
Website
Employees
103
